203 filings
Page 2 of 11
8-K
loh 1k8eid
14 Nov 22
Insulet Issues a Nationwide Voluntary Medical Device Correction for the OmnipodĀ® 5 Controller
4:33pm
8-K
61g41mj7351rcineou0
3 Nov 22
Results of Operations and Financial Condition
4:02pm
8-K
k2yam4mujbf0mdnfkn
17 Oct 22
Regulation FD Disclosure
8:30am
8-K
09ksqnw 3g7l0pecyj
27 Sep 22
Regulation FD Disclosure
8:57am
8-K
oijt oh1rfkrqodr
4 Aug 22
Recently Launched U.S. Full Market Release for OmnipodĀ® 5 - Now Available through Retail Pharmacies
4:04pm
8-K
1g73t1y92vjutj26
11 Jul 22
Other Events
7:26am
8-K
az5h4rh5
15 Jun 22
Entry into a Material Definitive Agreement
6:46pm
8-K
2aqzei3 64hjk50
27 May 22
Submission of Matters to a Vote of Security Holders
4:04pm
8-K
xncb83rjbxst
5 May 22
Insulet Announces CEO Transition
6:11pm
8-K
i5c g1fqb
5 May 22
Results of Operations and Financial Condition
4:05pm
8-K
lo31aa
1 Mar 22
Departure of Directors or Certain Officers
4:02pm
8-K
h9yrdfq66cia
24 Feb 22
Departure of Directors or Certain Officers
4:02pm
8-K
4rg w9t4itb0yfb
23 Feb 22
Results of Operations and Financial Condition
4:04pm
8-K
vpjwyq gx3
7 Feb 22
Insulet Announces Board Appointment of Elizabeth Weatherman and Retirement of David Lemoine
4:02pm
8-K
30e88sakdvjke
31 Jan 22
Insulet Announces FDA Clearance of its OmnipodĀ® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control
12:00am
8-K
4d7szyi491l 16
4 Nov 21
Results of Operations and Financial Condition
4:04pm
8-K
h2cv951ka9rn7clt
18 Oct 21
Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford
6:06am
8-K
eodo42nmzh7
4 Oct 21
Other Events
4:05pm
8-K
po9g34k3watfcle x9pn
5 Aug 21
Results of Operations and Financial Condition
4:07pm
8-K
pfl vpqubwo86jychcs
15 Jun 21
Unregistered Sales of Equity Securities
5:22pm